1. Home
  2. WGS vs HSAI Comparison

WGS vs HSAI Comparison

Compare WGS & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGS
    SELLHOLDBUYas of 2 days ago
  • HSAI
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • WGS 2017
  • HSAI 2014
  • Country
  • WGS United States
  • HSAI China
  • Employees
  • WGS N/A
  • HSAI N/A
  • Industry
  • WGS Retail: Computer Software & Peripheral Equipment
  • HSAI
  • Sector
  • WGS Technology
  • HSAI
  • Exchange
  • WGS Nasdaq
  • HSAI Nasdaq
  • Market Cap
  • WGS 2.0B
  • HSAI 1.8B
  • IPO Year
  • WGS N/A
  • HSAI 2023
  • Fundamental
  • Price
  • WGS $92.20
  • HSAI $15.20
  • Analyst Decision
  • WGS Strong Buy
  • HSAI
  • Analyst Count
  • WGS 5
  • HSAI 0
  • Target Price
  • WGS $82.60
  • HSAI N/A
  • AVG Volume (30 Days)
  • WGS 717.4K
  • HSAI 6.1M
  • Earning Date
  • WGS 04-28-2025
  • HSAI 03-10-2025
  • Dividend Yield
  • WGS N/A
  • HSAI N/A
  • EPS Growth
  • WGS N/A
  • HSAI N/A
  • EPS
  • WGS N/A
  • HSAI N/A
  • Revenue
  • WGS $305,450,000.00
  • HSAI $284,577,139.00
  • Revenue This Year
  • WGS $18.58
  • HSAI $65.90
  • Revenue Next Year
  • WGS $17.65
  • HSAI $47.82
  • P/E Ratio
  • WGS N/A
  • HSAI N/A
  • Revenue Growth
  • WGS 50.79
  • HSAI 10.66
  • 52 Week Low
  • WGS $8.53
  • HSAI $3.52
  • 52 Week High
  • WGS $115.60
  • HSAI $24.18
  • Technical
  • Relative Strength Index (RSI)
  • WGS 48.23
  • HSAI 40.41
  • Support Level
  • WGS $93.40
  • HSAI $17.90
  • Resistance Level
  • WGS $107.98
  • HSAI $19.45
  • Average True Range (ATR)
  • WGS 6.97
  • HSAI 2.12
  • MACD
  • WGS -0.87
  • HSAI -0.59
  • Stochastic Oscillator
  • WGS 27.49
  • HSAI 3.70

Stock Price Comparison Chart: WGS vs HSAI

WGS
HSAI
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025050100150200250300350400450500WGS VS HSAI

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. The Group organized its operations into two segments: the LiDAR segment and the gas detection segment, out of which LiDAR segments derives maximum revenue. Geographically, the company operates into North America, Mainland China, Europe and Other regions.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use